期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

心律植入装置相关感染危险因素及预防方法研究进展 被引量：5

Progress of risk factors and preventive strategies of cardiovascular implantable electronic device-related infection
原文传递
导出
摘要 心律植入装置相关感染是心律植入装置术后严重并发症之一。如发生心律植入装置相关感染,临床治疗困难。因此,早期认识心律植入装置相关感染的危险因素,积极预防,可降低心律植入装置相关感染的发生率。本文就心律植入装置相关感染的危险因素及预防方法的研究进展作一综述。 Cardiovascular implantable electronic device （CIED）-related infection has become one of the most serious complications after CIED implantation, and it is very difficult to treat. Therefore, early recognition of risk factors and active prevention are critical for reducing the incidence of CIED-related infection. This paper reviews the risk factors and preventive strategies of CIED-related infection.
作者 宋卫锋 王现青
机构地区 郑州大学人民医院 河南省人民医院心血管内科 河南省心血管病医院
出处 《中华实用诊断与治疗杂志》 2015年第7期625-627,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 河南省科技厅科技攻关项目(122300410059)
关键词 心律植入装置感染 危险因素 预防 进展 Cardiovascular implantable electronic device-related infectiom risk factor prevention progress
分类号 R541.7 [医药卫生—心血管疾病]
  • 相关文献

参考文献20

  • 1Tischer TS, Hollstein A, Voss W, et al. A historical perspective of pacemaker infections: 40-years single-centre experience[J].Europace, 2014,16 (2) : 235-240.
  • 2Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter- defibrillators in the United States 1993 to 2008[J].J Am Coll Cardiol,2011,58(10) : 1001-1006.
  • 3Sohail MR, Henrikson CA, Braid-Forbes MJ, et al. Mortality and cost associated with cardiovascular implantable electronic deviceinfections[J]. Arch Intern Med, 2011,171(20):1821- 1828.
  • 4Habib A, Le KY, Baddour LM, et al. Predictors of mortality in patients with cardiovascular implantable electronic device infections[J]. Am J Cardiol,2013,111(6) :874-879.
  • 5Sohail MR, Uslan DZ, Khan AH, et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter- defibrillator infection[J].Mayo Clin Proe, 2008,83 ( 1 ) : 46-53.
  • 6Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a Scientific Statement from the American Heart Association[J]. Circulation, 2010,121 (3) : 458-477.
  • 7Klug D, Balde M, Pavin D, et al. Risk factors related to infections of implanted pacemakers and cardioverter- defibrillators: results of a large prospective study [ J ]. Circulation, 2007,116(12) : 1349-1355.
  • 8Le KY, Sohail MR, Friedman PA, et al. Clinical features and outcomes of cardiovascular implantable electronic device infections due to staphylococcal species[J]. Am J Cardio,2012, 110(8) : 1143-1149.
  • 9Pakarinen S, Oikarinen L, Toivonen L. Short-term implantation-related complications of cardiac rhythm management device therapy: a retrospective single-centre 1-year survey[J]. Europaee,2010,12(1) : 103-108.
  • 10de Oliveira JC, Martinelli M, Nishioka SA, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial[J]. Circ Arrhythmia Electrophysiol, 2009,2 ( 1 ) : 29-34.

二级参考文献15

  • 1李剑明.起搏器系统感染全球概况.中国医学论坛报,2011,23:18-19.
  • 2Lekkerkerker JC, van Nieuwkoop C, Trines SA, et al. Risk factors and time delay associated with cardiac device infections: Leiden de- vice registry[J]. Heart,2009,95(9) : 715.
  • 3Kleemann T, Becker T, Strauss M, et al. Prevalence of bacterial colonization of generator pockets in implantable cardioverter defibril- lator patents without signs of infection undergoing gernerator replace- ment or lead revision[J]. Europace,2010,12( I ) : 58.
  • 4Chu VH, Crosslin DR, Friedman JY, et al. Staphylococcus aureus- bacteremia in patients with prosthetic devices: costs and outcomes [J]. Am J Med,2005,118(12) :1 416.
  • 5Chua JD, Wilkoff BL,Lee I,et al. Diagnosis and management of in- fections involving implantable electrophysiologic cardiac devices [ J ]. Ann Intem Med, 2000, 133(8) :604.
  • 6Wiegand UK, Lejeune D,Boguschewski F,et al. Pocket hematoma af- ter pacemaker or implantable cardioverter defibrillator surgery: influ- ence of patient morbidity, operation strategy, and perioperative anti- platelet/anticoagulation therapy [ J ]. Chest, 2004,126 (4) : 1 177.
  • 7Baddour LM, Epstein AE, Erickson CC, eta. 1 Update on cardio- vascular implantable electronic device infections and their manage- ment: a scientific statement from the American heart association [J]. Circulation, 2010, 121 (3) : 458.
  • 8Raad D, Irani J, Akl EG, et al. Implantable electrophysiologic car- diac device infections: a risk factor analysis[J]. Eur J Clin Micro- biol Infect Dis, 2012,31 ( 11 ) :3 015.
  • 9Bloom H, Heeke B, Leon A, et al. Renal insufficiency and the risk of infection from pacemaker or defibrillator surgery[ J]. Pacing Clin Electrophysio, 2006,29 : 142.
  • 10Lekkerkerker JC, Van Nicuwkoop C, Trines SA, et al. Risk factors and time delay associated with cardiac device infections: Leiden de- vice registry[J]. Heart,2009,95:715.

共引文献3

同被引文献40

  • 1武梦威,胡一东,杨柳,胡凯,苏浩,徐健.单中心无导线起搏器植入的疗效观察[J].临床心电学杂志,2023,32(1):12-15. 被引量：1
  • 2Epstein AE, Di Marco JP, Ellenbogen KA, et al. 2012ACCF/ AHA/HRS focused update incorporated into the ACCF/AHA/ HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society[J]. J Am Coil Cardi- ol,2013,22,61 (3) :6.
  • 3Baddour LM, Epstein AE,Erickson CC, et al. Update on cardio- vascular implantable electronic device infections and their man- agement:a Scientific Statement from the American Heart Asso- ciation [J]. Circulation, 2010,121 (3) : 458.
  • 4Sohail MR, Henrikson CA, Braid-Forbes MJ,et al. Mortality and cost associated with cardiovascular implantable electronic device infections[J]. Arch Intern Meal,2011,171(20) :121.
  • 5Lekkerkerker JC, van Nieuwkoop C, Trines SA, et al. Risk factors and time delay associated with cardiac device infections: Leiden device registry[J]. Heart,2009,95(9) :715.
  • 6Cano O, Munoz B, Tejada D, et al. Evaluation of a new stand- ardized protocol for the perioperative management of chronically anticoagulated patients receiving implantablc cardiac arrhythmia devices[J]. Heart Rhythm,2012,9(3) :361.
  • 7Birnie DH, Healey JS, Wells GA,et al. Pacemaker or defibril- lator surgery without interruption of anticoagulation[J]. N Eagl J Med, 2013, 368(22) :284.
  • 8de Oliveira JC, Martinelli M, Nishioka SA, et al. Efficacy of antibiotic prophylaxis before the implantation o{ pacemakers and cardioverter defibrillators: Results of a large, prospective, ran- domized, double-blinded, placebo-controlled triali-J]. Cire Ar- rhythmia Electrophysiol, 2009,2(1) :29.
  • 9范肖春,余小春,程旭峰.心内科患者感染相关因素分析及预防对策研究[J].中华医院感染学杂志,2014,24(4):874-876. 被引量：16
  • 10王鹏,卢静海,王贺玲,于丽天,谭慧琼,熊长明,杨跃进.感染性心内膜炎368例临床分析[J].中华心血管病杂志,2014,42(2):140-144. 被引量：45

引证文献5

二级引证文献13

中华实用诊断与治疗杂志
2015年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部